تقرير
ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)
| العنوان: | ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS) |
|---|---|
| المؤلفون: | Buti, M., Flisiak, R., Rasenack, J., Davis, G., Alberti, A., Goeser, T., Stanciu, C., Chuang, W. -L., Kao, J. -H., Streinu-Cercel, A., Hofstetter, G., Wang, J., Avila, C., Orsenigo, R., Tabak, F. |
| المساهمون: | Hospital Universitari Vall d''Hebron ,, 141453 |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Sağlık Bilimleri, Klinik Tıp, GASTROENTEROLOJİ VE HEPATOLOJİ, Klinik Tıp (MED), Tıp, Dahili Tıp Bilimleri, İç Hastalıkları, Gastroenteroloji-(Hepatoloji) |
| نوع الوثيقة: | report |
| اللغة: | English |
| العلاقة: | Buti M., Flisiak R., Rasenack J., Davis G., Alberti A., Goeser T., Stanciu C., Chuang W. -. , Tabak F., Kao J. -. , et al., "ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)", International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, cilt.58; vv_1032021; av_60e7879e-7540-4d70-a6f7-cb86080698d3; http://hdl.handle.net/20.500.12627/67606Test; https://doi.org/10.1016/s0168-8278Test(13)61420-8; 58 |
| DOI: | 10.1016/s0168-8278(13)61420-8 |
| الإتاحة: | https://doi.org/20.500.12627/67606Test https://doi.org/10.1016/s0168-8278Test(13)61420-8 https://hdl.handle.net/20.500.12627/67606Test |
| رقم الانضمام: | edsbas.CEB3CB83 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s0168-8278(13)61420-8 |
|---|